Auditors
Remuneration
Incentive program
Management
Board Of Directors
Committees
Nomination Committee
General Meeting
Articles Of Association
Governance Structure
Corporate Governance Reports

Management

The role of CEO is, subordinate to the Board of Directors and its main task is to carry out the daily management of Xbrane and the daily activities of the Company. The Board of Director’s rules of procedure and instructions for the CEO stipulate for which matters the Board of Directors is responsible to decide upon, and which decisions fall within the CEO’s area of responsibility. The CEO is also responsible for producing reports and necessary data for decision-making ahead of Board meetings and for presenting the material at Board meetings.

Xbrane has a management team consisting of five people, which in addition to the CEO is comprised of the COO/Head of Biosimilars, CFO/Head of IR, Head of Technical Operations and Head of Quality Assurance.

Management Team

CEO

Martin Åmark

Since 2015

Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including life science and pharmaceuticals.

Shares: 39,297

COO & Head of Biosimilars

Siavash Bashiri

Since 2012

Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.

Shares: 18,367

Interim CFO & Head of IR

Jane Benyamin

Since 2025

Jane Benyamin has a master’s degree in business administration from Södertörns Högskola. She has operated in the Life Science sector for 20 years, having held Senior Finance roles such as Chief Accounting Officer at Oncopeptides, CFO Bluefish Pharmaceuticals and Finance Manager at Pensa Pharma.

Shares: 0

Head of Technical Operations

Anders Wallström

Since 2020

Anders Wallström holds a M. Sc. in Biotechnology from Royal Institute of Technology in Stockholm. He has more than 20 years of experience from process development, manufacturing and validation at SOBI and Biovitrum. Furthermore, he has significant experience from coordinating contract manufacturers for commercial products for both small molecule and biotech products.

Shares: 1,503

Head of Quality Assurance

Björn Lager

Since 2025

Björn Lager holds a M. Sc. in Chemistry from Royal Institute of Technology in Stockholm. He has more than 15 years of experience from Quality Assurance and Quality Control at Octapharma. Furthermore, he has significant experience from Health authority inspections and supplier audits for commercial products for both aseptically filled and biotech products.

Shares: 612

NamePositionMember of the senior management sinceEmployed at the Company sinceHoldings in Xbrane - Shares
Martin ÅmarkCEO2015201539,297
Siavash BashiriCOO & Head of Biosimilars2012201218,367
Jane BenyaminInterim CFO & Head of IR202520250
Anders WallströmHead of Technical Operations202020191,503
Björn LagerHead of Quality Assurance20252020612